Last reviewed · How we verify
Yangzhengxiaoji Capsule — Competitive Intelligence Brief
marketed
Oncology
Small molecule
Live · refreshed every 30 min
Target snapshot
Yangzhengxiaoji Capsule (Yangzhengxiaoji Capsule) — Shandong Cancer Hospital and Institute. Yangzhengxiaoji Capsule is a traditional Chinese medicine formulation designed to support immune function and promote recovery in cancer patients.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Yangzhengxiaoji Capsule TARGET | Yangzhengxiaoji Capsule | Shandong Cancer Hospital and Institute | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Yangzhengxiaoji Capsule CI watch — RSS
- Yangzhengxiaoji Capsule CI watch — Atom
- Yangzhengxiaoji Capsule CI watch — JSON
- Yangzhengxiaoji Capsule alone — RSS
Cite this brief
Drug Landscape (2026). Yangzhengxiaoji Capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/yangzhengxiaoji-capsule. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab